BIONANO GENOMICS INC (BNGO)
NASDAQHealth CareMedical - Instruments & SuppliesSnapshot 2026-11-05
$1.10-7.56%
Close 2026-11-05 · 1-day change
NASDAQHealth CareMedical - Instruments & SuppliesSnapshot 2026-11-05
QuarterlyIQ Insights · BNGO
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenues | |||||||||
| Revenues | 30.2 | 28.5 | 30.8 | 36.1 | 27.8 | 18.0 | 8.5 | 10.1 | 12.0 |
| Total Revenues | — | — | — | — | — | — | — | — | 12.0 |
| Cost of Revenues | 15.8 | 15.3 | 30.4 | 26.6 | 21.9 | 14.1 | 5.7 | 6.8 | 8.7 |
| Operating Expenses & Income | |||||||||
| Selling, General & Admin | 34.3 | 35.2 | 51.9 | 92.8 | 88.6 | 58.5 | 31.1 | 20.2 | 14.2 |
| R&D Expenses | 12.2 | 11.4 | 24.8 | 54.0 | 49.0 | 22.5 | 10.3 | 9.1 | 9.5 |
| Operating Income | (32.2) | (33.3) | (104.0) | (215.2) | (131.7) | (77.1) | (38.6) | (25.9) | (20.4) |
| Earnings from Continuing Operations | |||||||||
| Interest Expense | — | — | — | 5.1 | 0.3 | 0.9 | 2.5 | 2.3 | 1.4 |
| Interest & Investment Income | — | 1.0 | 1.5 | 3.3 | 1.5 | 0.4 | — | — | — |
| Net Interest Expenses | — | — | — | 1.8 | (1.2) | 0.5 | — | — | — |
| Other Non-Operating Income / Expenses | 0.1 | 7.0 | (8.0) | (17.2) | 1.0 | (1.1) | (2.5) | (3.9) | 1.9 |
| Asset Writedown | — | — | 19.7 | — | — | — | — | — | — |
| EBT, Incl. Unusual Items | (32.1) | (26.3) | (112.0) | (232.4) | (130.7) | (78.2) | (41.1) | (29.8) | (18.5) |
| Income Tax Expense | 0.1 | 0.1 | 0.0 | 0.1 | 1.9 | (5.7) | 0.0 | 0.0 | 0.0 |
| Net Income | |||||||||
| Net Income | (32.2) | (26.4) | (112.0) | (232.5) | (132.6) | (72.4) | (41.1) | (29.8) | (18.5) |
| Per Share | |||||||||
| Basic EPS | (2.79) | (4.85) | (88.13) | (408.60) | (4.58) | (0.26) | — | — | — |
| Diluted EPS | (2.79) | (4.85) | (88.13) | (408.60) | (4.58) | (0.26) | — | — | — |
| Revenue per Share | 2.61 | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 11.5 | 5.4 | 1.3 | 0.6 | 28.9 | 276.8 | — | — | — |
| Diluted Weighted Avg Shares | 11.5 | 5.4 | 1.3 | 0.6 | 28.9 | 276.8 | — | — | — |
| Supplemental | |||||||||
| EBITDA | — | (23.8) | (90.0) | (201.5) | (122.1) | (73.8) | (37.1) | (24.7) | (19.1) |
| EBIT | (32.2) | (33.3) | (104.0) | (215.2) | (131.7) | (77.1) | (38.6) | (25.9) | (20.4) |
| Effective Tax Rate | -0.2% | — | — | -0.0% | -1.4% | 7.3% | -0.1% | -0.1% | -0.1% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.